New Zealand markets open in 6 hours 16 minutes

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.54-0.12 (-2.12%)
As of 09:43AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts4345
Avg. Estimate-0.23-0.21-0.27-0.8
Low estimate-0.26-0.25-0.29-1.05
High estimate-0.21-0.19-0.25-0.64
Year ago EPS-1.210.04-2.56-0.27
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts6477
Avg. Estimate14.44M16.92M45.41M85.98M
Low estimate13.47M15.5M44M60M
High estimate16.1M18.3M47.3M115.1M
Year ago sales7.35M7.34M17.4M45.41M
Sales growth (year/est)96.50%130.50%160.90%89.30%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.17-0.21-0.21-0.26
Actual EPS-1.210.04-0.110.03
Difference-1.040.250.10.29
Surprise %-611.80%119.00%47.60%111.50%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.23-0.21-0.27-0.8
7 days ago-0.23-0.21-0.27-0.8
30 days ago-0.23-0.21-0.27-0.8
60 days ago-0.23-0.21-0.27-0.8
90 days ago-0.23-0.18-0.66-0.72
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOCULIndustrySector(s)S&P 500
Current qtr.81.00%N/AN/AN/A
Next qtr.-625.00%N/AN/AN/A
Current year89.50%N/AN/AN/A
Next year-196.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A